Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

fool.com - Reuben Gregg Brewer - Big Pharma Dividend Stock BMY Could Help Turn $100,000 Into a Seven-Figure Retirement
Big Pharma Dividend Stock BMY Could Help Turn $100,000 Into a Seven-Figure Retirement
The Motley Fool

The S&P 500 index (^GSPC 0.43%) is offering a tiny 1.1% dividend yield today. The average pharmaceutical stock yields around 1.7%. Bristol Myers Squibb (BMY +2.08%), however, is offering investors a yield of 4%. If you're a dividend investor…

mediabistro.com - Media News - New to The Street to Broadcast Executive Leadership Interviews Featuring Medicus Pharma Ltd. (NASDAQ:MDCX), CitroTech (NYSE:CITR), Vivos Therapeutics, Inc. (NASDAQ:VVOS), and Virtuix Holdings ($VTIX) on Bloomberg Television Tonight at 6:30 PM EST
New to The Street to Broadcast Executive Leadership Interviews Featuring Medicus Pharma Ltd. (NASDAQ:MDCX), CitroTech (NYSE:CITR), Vivos Therapeutics, Inc. (NASDAQ:VVOS), and Virtuix Holdings ($VTIX) on Bloomberg Television Tonight at 6:30 PM EST
Mediabistro

The Show Will Also Air Across Latin America and MENA 1230 pm local time. New to The Street will broadcast nationally tonight at 6:30 PM EST on Bloomberg Television, featuring executive leadership interviews with Medicus Pharma Ltd. (NASDAQ:MDCX)…

dev.to - Sri Naimisha Reddy  - Why Data Engineering Matters in Healthcare and Pharma
Why Data Engineering Matters in Healthcare and Pharma
DEV Community

A pharmaceutical manufacturing unit was preparing to release a critical batch of medication. Everything looked perfect — stability tests passed, quality checks cleared, documentation complete. Just… a missing timestamp. That single…

marketbeat.com - Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA) Short Interest Update
Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA) Short Interest Update
MarketBeat

Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA - Get Free Report) saw a large decline in short interest during the month of February. As of February 13th, there was short interest totaling 125,617 shares, a decline of 40.3% from the January 29th…

marketbeat.com - Fox Run Management L.L.C. Reduces Holdings in BridgeBio Pharma, Inc. $BBIO
Fox Run Management L.L.C. Reduces Holdings in BridgeBio Pharma, Inc. $BBIO
MarketBeat

Fox Run Management L.L.C. decreased its position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 79.6% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund…

marketbeat.com - JPMorgan Chase & Co. Has $37.04 Million Position in NewAmsterdam Pharma Company N.V. $NAMS
JPMorgan Chase & Co. Has $37.04 Million Position in NewAmsterdam Pharma Company N.V. $NAMS
MarketBeat

JPMorgan Chase & Co. lessened its position in NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 10.7% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,302,498 shares of…

techcrunch.com - Connie Loizos - The trap Anthropic built for itself
The trap Anthropic built for itself
TechCrunch

Friday afternoon, just as this interview was getting underway, a news alert flashed across my computer screen: the Trump administration was severing ties with Anthropic, the San Francisco AI company founded in 2021 by Dario Amodei and other former…

rediff.com - Sanket Koul - Abbott Bets On Semaglutide Boom
Abbott Bets On Semaglutide Boom
Rediff.com

Abbott will be the second company to secure sole distribution rights for Novo's semaglutide portfolio in India, after Emcure Pharma. Drug maker Abbott on Friday said it has tied up with Novo Nordisk India to commercialise Extensior, a semaglutide…

yahoo.com - Ricardo Pillai - Erasca, Inc. (ERAS): A Bull Case Theory
Erasca, Inc. (ERAS): A Bull Case Theory
Yahoo!

We came across a bullish thesis on Erasca, Inc. on Danny's Substack by Danny Green. In this article, we will summarize the bulls' thesis on ERAS. Erasca, Inc.'s share was trading at $12.39 as of February 19th. Photo by National Cancer Institute on…

yahoo.com - Vardah Gill - UBS Raises Viatris (VTRS) Price Target as Cost Savings and Growth Outlook Improve
UBS Raises Viatris (VTRS) Price Target as Cost Savings and Growth Outlook Improve
Yahoo!

Viatris Inc. (NASDAQ: VTRS) is included among the 13 Best March Dividend Stocks to Buy. On February 27, UBS raised its price recommendation on Viatris Inc. (NASDAQ:VTRS) to $20 from $18. It maintained a Buy rating on the stock. The firm noted that…

fool.com - Katie Brockman - River Road Loads Up on ATR With 917,000 Shares in New Position
River Road Loads Up on ATR With 917,000 Shares in New Position
The Motley Fool

According to a Securities and Exchange Commission (SEC) filing dated February 24, 2026, River Road Asset Management, LLC established a new position in AptarGroup (ATR +1.35%) by acquiring 917,670 shares. The estimated value of this trade is $111.92…

forbes.com - Richard Menger MD MPA - Alabama Hospital Price Transparency: Only 54% Offer A Cost Calculator
Alabama Hospital Price Transparency: Only 54% Offer A Cost Calculator
Forbes

Hospital price transparency is difficult to accomplish in real time. Americans are drowning in unpredictable healthcare bills, yet the federal push for hospital price transparency—meant to let patients shop like savvy consumers—often…

thehindu.com - Rajesh B Nair - PM Modi to lay foundation for projects worth ₹1,571 crore in Puducherry
PM Modi to lay foundation for projects worth ₹1,571 crore in Puducherry
The Hindu

Coinciding with the visit of Prime Minister Narendra Modi to Puducherry for laying the foundation stone for 74 projects – estimated to cost around ₹1,571 crore – and the inauguration of 19 completed works worth ₹1,142…

indianexpress.com - Education Desk - IIM Mumbai Placements 2026: Rs 71.4 lakh highest package; 3 opt for entrepreneurship
IIM Mumbai Placements 2026: Rs 71.4 lakh highest package; 3 opt for entrepreneurship
The Indian Express

4 min read New Delhi Make us preferred source on Google The Indian Institute of Management Mumbai (IIM Mumbai) in its final placement season for the 2024-2026 batch received 502 offers secured across its MBA, MBA-Operations and Supply Chain…

thehindubusinessline.com - Bandu's Blockbusters For March 1, 2026
Bandu's Blockbusters For March 1, 2026
BusinessLine

On April 1, four years ago, piqued by the incessant jokes in the village at his expense, Bandu Barve decided he'd had enough. It was time for him to turn ‘smart'. His dead granny's voice rang in his ears — “Read the papers…

Receive a Daily briefing on Pharma Industry News

Get Started